A trial looking at cediranib for ovarian cancer that has come back (ICON 6)

Overview

Cancer types:

Ovarian cancer

Status:

Results

Phase:

Phase 3

Details

This trial looked at cediranib alongside and after chemotherapy for ovarian cancer. It was for people whose cancer had come back after having chemotherapy that included a .

The trial was partly supported by Cancer Research UK. It was open for people to join between 2007 and 2011. The trial team have published several papers with results from this trial.

Recruitment start: 13 November 2007

Recruitment end: 23 December 2011

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Jonathan Ledermann

Supported by

AstraZeneca

Canadian Cancer Society Research Institute

Cancer Australia

Cancer Research UK

Medical Research Council (MRC)

National Gynaecological Cancer Centre

NIHR Clinical Research Network: Cancer

Other information

This is Cancer Research UK trial number CRUK/07/025.

Last reviewed: 21 Nov 2023

CRUK internal database number: 713

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.